Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
Press ReleasesJan 21, 2021Helix Launches a COVID-19 Viral Surveillance Dashboard to Track Emergence and Prevalence of New SARS-CoV-2 Variants
NewsJan 15, 2021Dr. James Lu Interview on New COVID-19 variants discovered in the U.S.Critical Mention
NewsJan 15, 2021Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance InfrastructureBusiness Wire
NewsJan 11, 2021Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk TestGenomeWeb
Press ReleasesJan 11, 2021Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform
Blog Jan 11, 2021Update on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US
Blog Dec 31, 2020SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California
ResearchDec 20, 2020S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the USMEDRXIV
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025